Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antoni Torres

Showing results (491-500 of 794) with videos related to

Pageof 80
Sort By:
Chest|August 6, 2019
Community-Acquired Pneumonia Patients at Risk for Early and Long-term Cardiovascular Events Are Identified by Cardiac BiomarkersRosario Menéndez, Raúl Méndez, Irene Aldás, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 3, 2016
The SAATELLITE and EVADE Clinical Studies Within the COMBACTE Consortium: A Public-Private Collaborative Effort in Designing and Performing Clinical Trials for Novel Antibacterial Drugs to Prevent Nosocomial PneumoniaBruno François, Jean Chastre, Philippe Eggiman, et al.
Infectious Diseases and Therapy|August 10, 2021
Clinical and Microbiological Outcomes of Ceftazidime-Avibactam Treatment in Adults with Gram-Negative Bacteremia: A Subset Analysis from the Phase 3 Clinical Trial ProgramJohn E Mazuski, Florian Wagenlehner, Antoni Torres, et al.
Plos One|November 5, 2010
Common variants of TLR1 associate with organ dysfunction and sustained pro-inflammatory responses during sepsisMaria Pino-Yanes, Almudena Corrales, Milena Casula, et al.
Infection|August 31, 2021
COVID-19 in young and middle-aged adults: predictors of poor outcome and clinical differencesEva Tabernero, Luis A Ruiz, Pedro P España, et al.
Respiratory Medicine|June 12, 2004
Non-infectious and unusual infectious mimics of community-acquired pneumoniaJosé Wellington Alves dos Santos, Antoni Torres, Gustavo Trindade Michel, et al.
JAMA|February 18, 2015
Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trialAntoni Torres, Oriol Sibila, Miquel Ferrer, et al.
Chest|October 17, 2021
Cardiovascular Events During and After Bronchiectasis Exacerbations and Long-term MortalityRaúl Méndez, Laura Feced, Victoria Alcaraz-Serrano, et al.
Plos One|August 9, 2017
Time to blood culture positivity as a predictor of clinical outcomes and severity in adults with bacteremic pneumococcal pneumoniaCatia Cillóniz, Adrian Ceccato, Cristina de la Calle, et al.
The Lancet. Infectious Diseases|December 20, 2017
Ceftazidime-avibactam versus meropenem in nosocomial pneumonia, including ventilator-associated pneumonia (REPROVE): a randomised, double-blind, phase 3 non-inferiority trialAntoni Torres, Nanshan Zhong, Jan Pachl, et al.
Pageof 80

Showing results (491-500 of 794) with videos related to

Sort By:
Pageof 80
Chest|August 6, 2019
Community-Acquired Pneumonia Patients at Risk for Early and Long-term Cardiovascular Events Are Identified by Cardiac BiomarkersRosario Menéndez, Raúl Méndez, Irene Aldás, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 3, 2016
The SAATELLITE and EVADE Clinical Studies Within the COMBACTE Consortium: A Public-Private Collaborative Effort in Designing and Performing Clinical Trials for Novel Antibacterial Drugs to Prevent Nosocomial PneumoniaBruno François, Jean Chastre, Philippe Eggiman, et al.
Infectious Diseases and Therapy|August 10, 2021
Clinical and Microbiological Outcomes of Ceftazidime-Avibactam Treatment in Adults with Gram-Negative Bacteremia: A Subset Analysis from the Phase 3 Clinical Trial ProgramJohn E Mazuski, Florian Wagenlehner, Antoni Torres, et al.
Plos One|November 5, 2010
Common variants of TLR1 associate with organ dysfunction and sustained pro-inflammatory responses during sepsisMaria Pino-Yanes, Almudena Corrales, Milena Casula, et al.
Infection|August 31, 2021
COVID-19 in young and middle-aged adults: predictors of poor outcome and clinical differencesEva Tabernero, Luis A Ruiz, Pedro P España, et al.
Respiratory Medicine|June 12, 2004
Non-infectious and unusual infectious mimics of community-acquired pneumoniaJosé Wellington Alves dos Santos, Antoni Torres, Gustavo Trindade Michel, et al.
JAMA|February 18, 2015
Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trialAntoni Torres, Oriol Sibila, Miquel Ferrer, et al.
Chest|October 17, 2021
Cardiovascular Events During and After Bronchiectasis Exacerbations and Long-term MortalityRaúl Méndez, Laura Feced, Victoria Alcaraz-Serrano, et al.
Plos One|August 9, 2017
Time to blood culture positivity as a predictor of clinical outcomes and severity in adults with bacteremic pneumococcal pneumoniaCatia Cillóniz, Adrian Ceccato, Cristina de la Calle, et al.
The Lancet. Infectious Diseases|December 20, 2017
Ceftazidime-avibactam versus meropenem in nosocomial pneumonia, including ventilator-associated pneumonia (REPROVE): a randomised, double-blind, phase 3 non-inferiority trialAntoni Torres, Nanshan Zhong, Jan Pachl, et al.
Pageof 80